Total Payments
$492,236
2024 Payments
$126,053
Companies
17
Transactions
482
Medicare Patients
1,914
Medicare Billing
$264,314
Payment Breakdown by Category
Other$443,025 (90.0%)
Travel$25,877 (5.3%)
Food & Beverage$13,157 (2.7%)
Consulting$6,135 (1.2%)
Education$4,042 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $443,025 | 166 | 90.0% |
| Travel and Lodging | $25,877 | 71 | 5.3% |
| Food and Beverage | $13,157 | 233 | 2.7% |
| Consulting Fee | $6,135 | 7 | 1.2% |
| Education | $4,042 | 5 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $293,619 | 266 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $168,404 | 156 | $0 (2024) |
| Amgen Inc. | $25,062 | 21 | $0 (2023) |
| INTUITIVE SURGICAL, INC. | $4,277 | 5 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $366.96 | 5 | $0 (2020) |
| Mylan Specialty L.P. | $85.01 | 5 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $81.68 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.18 | 5 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $59.24 | 4 | $0 (2018) |
| Mallinckrodt LLC | $53.40 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126,053 | 113 | AstraZeneca Pharmaceuticals LP ($89,649) |
| 2023 | $148,560 | 137 | GlaxoSmithKline, LLC. ($100,436) |
| 2022 | $152,658 | 126 | GlaxoSmithKline, LLC. ($97,018) |
| 2021 | $51,065 | 54 | GlaxoSmithKline, LLC. ($50,646) |
| 2020 | $13,020 | 13 | GlaxoSmithKline, LLC. ($12,884) |
| 2019 | $295.07 | 6 | GlaxoSmithKline, LLC. ($141.35) |
| 2018 | $564.71 | 32 | Merck Sharp & Dohme Corporation ($114.83) |
| 2017 | $19.50 | 1 | Mylan Specialty L.P. ($19.50) |
All Payment Transactions
482 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $131.32 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $198.32 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $68.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.90 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $100.12 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $11.66 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $83.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $9.92 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $62.09 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $1,503.95 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $435.48 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $429.59 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.04 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $125.96 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $247.71 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 699 | 897 | $379,679 | $74,810 |
| 2022 | 7 | 298 | 434 | $135,693 | $44,633 |
| 2021 | 12 | 464 | 701 | $190,435 | $63,112 |
| 2020 | 10 | 453 | 750 | $256,313 | $81,759 |
Total Patients
1,914
Total Services
2,782
Medicare Billing
$264,314
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 83 | 187 | $52,921 | $16,567 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 133 | $38,703 | $12,399 | 32.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 32 | 63 | $57,141 | $10,048 | 17.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 60 | $25,500 | $7,597 | 29.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 58 | $32,596 | $7,339 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 85 | $15,910 | $5,334 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $18,392 | $4,480 | 24.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $15,964 | $4,159 | 26.1% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 12 | 12 | $20,532 | $1,602 | 7.8% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 11 | 11 | $26,268 | $1,320 | 5.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $5,808 | $916.32 | 15.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 12 | 12 | $35,652 | $862.20 | 2.4% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 12 | 12 | $3,504 | $598.80 | 17.1% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 60 | 60 | $2,400 | $558.94 | 23.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 16 | $13,184 | $320.18 | 2.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 38 | 38 | $1,900 | $317.45 | 16.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 38 | 38 | $1,748 | $235.20 | 13.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 12 | 12 | $480.00 | $85.47 | 17.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 12 | 12 | $444.00 | $68.09 | 15.3% |
| 31623 | Exam of lung airways using an endoscope | Facility | 2023 | 12 | 12 | $10,632 | $3.34 | 0.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 38 | 69 | $44,571 | $11,831 | 26.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 64 | 138 | $33,273 | $11,052 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 108 | $17,122 | $6,921 | 40.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $13,161 | $4,339 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $11,940 | $4,097 | 34.3% |
About Dr. Alexis Smith, D.O
Dr. Alexis Smith, D.O is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1235428103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Smith, D.O has received a total of $492,236 in payments from pharmaceutical and medical device companies, with $126,053 received in 2024. These payments were reported across 482 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($443,025).
As a Medicare-enrolled provider, Smith has provided services to 1,914 Medicare beneficiaries, totaling 2,782 services with total Medicare billing of $264,314. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Huntersville, NC
- Active Since 03/31/2011
- Last Updated 10/06/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235428103
Products in Payments
- NUCALA (Biological) $234,417
- TEZSPIRE (Biological) $164,694
- AREXVY (Drug) $58,303
- AIRSUPRA (Drug) $24,496
- Da Vinci Surgical System (Device) $4,277
- TRELEGY ELLIPTA (Drug) $597.74
- ZERBAXA (Drug) $366.96
- ANORO ELLIPTA (Drug) $67.92
- STIOLTO RESPIMAT (Drug) $67.34
- DUPIXENT (Biological) $64.58
- LONHALA MAGNAIR (Drug) $59.24
- ACTHAR (Biological) $53.40
- DUPIXENT (Drug) $40.53
- FASENRA (Drug) $39.74
- ANORO (Drug) $38.96
- Yupelri (Drug) $32.85
- Perforomist (Drug) $32.66
- SMARTVEST (Device) $20.43
- Dymista (Drug) $19.50
- ImmunoCAP (Device) $18.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
Internal Medicine $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Internal Medicine $33,144
Dr. William Mitchell, Md, MD
Internal Medicine — Payments: $31,201
Internal Medicine $31,201
Poras Patel
Internal Medicine — Payments: $20,257
Internal Medicine $20,257
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309
Internal Medicine $17,309
Dr. Stacy Le, M.d, M.D
Internal Medicine — Payments: $13,752
Internal Medicine $13,752